Beta-carotene increases lung cancer incidence in cigarette smokers.

Clinical trials were designed to validate the protective effect of β-carotene in populations of cigarette smokers at high risk for lung cancer development. Strikingly, an increase in lung cancer resulted following β-carotene supplementation in two separate studies in Finland and the United States. These trials were conducted without any evidence that β-carotene prevents lung cancer in animal models.